First Business Growth Funding Finances Multiple COVID-19 Vaccine Trials

First Business Growth Funding, a division of First Business Capital Corp., announced today that it is financing multiple COVID-19 vaccine trials at various sites throughout the United States. The COVID-19 vaccine trials are in Stages II and III and involve thousands of subjects.

Bill Elliott, President of First Business Growth Funding, stated, “We are excited to be able to do our small part to help fight this disease. This type of financing does not fit the norms of traditional factoring, so we had to be creative in structuring a program that benefits our clients while also maintaining our credit integrity. We are very proud of the work that our clients are doing on the front lines.”

About First Business

First Business Growth Funding, the accounts receivable financing arm of First Business Financial Services, Inc., provides factoring solutions to service providers, importers, and manufacturers of all sizes throughout the United States with transactions ranging from $100,000 to $10 million.

First Business Financial Services, Inc. (Nasdaq: FBIZ) focuses on the unique needs of businesses, business executives, and high net worth individuals. First Business Bank offers business banking, specialty finance, and private wealth management solutions, and because of its niche focus, is able to provide its clients with unmatched expertise, accessibility, and responsiveness.

Member FDIC, First Business’ corporate headquarters are at 401 Charmany Drive in Madison, WI. For additional information, visit www.firstbusiness.com or call 608-238-8008. The First Business logo is available at http://www.firstbusiness.com/logo/ .